Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
At the 3rd annual ISPE-FDA CGMP Conference, ISPE announced the official launch of its Metrics Pilot Program. The launch of the pilot, headed by ISPE’s PQLI® Quality Metrics Team, is a major milestone in the overall project from ISPE. The pilot is now...
read more
Evotec announced an integrated drug discovery collaboration with STORM Therapeutics to develop new small molecule epigenetic drugs for oncology and other therapeutic areas.
read more
Thursday, November 02, 2017
Sterigenics International has acquired Toxikon Europe N.V., the European division of Toxikon Corporation, a Bedford, Mass.-based preclinical contract research organization.
read more
Thursday, December 14, 2017
reMYND and Novo Nordisk have entered into a license agreement to further develop reMYND's ReS39 therapeutic program of diabetes.
read more
Sai Life Sciences announced that it has received Establishment Inspection Reports (EIR) from the US Food and Drug Administration (USFDA) for its R&D (Unit II, Hyderabad), and Manufacturing (Unit IV, Bidar) sites in India.
read more
Friday, February 14, 2020
WuXi Biologics has released the following statement addressing the Coronavirus outbreak.
read more
Monday, November 05, 2018
Recro Gainesville has added a 24,000-square-foot facility near its existing 97,000-square-foot contract pharmaceutical development and manufacturing plant.
read more
Wednesday, April 29, 2020
A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials has been announced by Quotient Sciences and CytoAgents.
read more
Friday, December 20, 2013
OsoBio has reaffirmed its long-standing partnership with the Drug, Chemical and Associated Technologies Association (DCAT) by accepting new volunteer leadership positions within the organization.
read more
Tuesday, February 18, 2014
Camargo Pharmaceutical Services’ Ready 4 Action
proprietary feasibility assessment enables drug developers — generic companies in particular
— to identify viable products to bring to market. Camargo will be exhibiting at the Generic
Pharmaceutical...
read more
International private equity firm, Cinven, has agreed to acquire Bioclinica, a global provider of clinical trial services and technology to contract research organizations (CROs) and pharmaceutical companies, based in Pennsylvania, from Water Street ...
read more
Emmes – a global, full-service Contract Research Organization (CRO) will introduce to market its third generation version of Advantage eClinical at Society for Clinical Trials (SCT) in San Diego, May 15th – 18th.
read more
Catalent announced a deal to acquire a clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan, from Teva-Takeda.
read more
Takeda and Shire announced they have reached agreement on the terms of a recommended offer pursuant to which Takeda will acquire the entire share capital of Shire.
read more
Andelyn Biosciences, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Grace Science, LLC, to tech transfer and manufacture GS-100, a suspension process AAV NGLY1 gene therapy for Phase I/II/...
read more